Video

Residual Cardiovascular Risk

Ian Riddock, MD, describes residual cardiovascular risk, both with and without the use of statin therapies.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo